Aytu Biopharma Inc share price logo

Aytu Biopharma Inc Share Price

NASDAQ: AYTU

Small Cap

$2.65

+0.04

(+1.53%)

as on

Aytu Biopharma Inc Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    $2.60
    $2.65
    downward going graph

    1.89%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.95
    $3.07
    downward going graph

    64.15%

    Downside

    15.66%

    Upside

    downward going graph

Aytu Biopharma Inc share price movements today

Previous Close
$2.61
Open
$2.61
Volume
1.1M
Day's Low - High
$2.60 - $2.65
52 Week Low - High
$0.95 - $3.07

Aytu Biopharma Inc Historical Returns

1 Month Return
+ 14.98 %
3 Month Return
+ 2.76 %
1 Year Return
+ 110.48 %
3 Year Return
+ 27.32 %
5 Year Return
-98.48 %

Aytu Biopharma Inc Stock Fundamentals & Key Indicators

Check Aytu Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.0M

EPS (TTM)

-1.465

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

4.0M

Revenue (TTM)

62.6M

Profit Margin

-39.02%

Return On Equity TTM

-109.23%

Aytu Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aytu Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Aytu Biopharma Inc image
Aytu Biopharma Inc
BUY$28.0M-98.48%NA-39.02%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.0BNA18.8141.94%
Viatris Inc. image
Viatris Inc.
HOLD$15.2B-6.85%-21.95-24.58%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$44.8BNA20.5515.11%
Zoetis Inc. image
Zoetis Inc.
BUY$51.0B-25.87%19.2528.24%

Stock Returns calculator for Aytu Biopharma Inc Stock including INR - Dollar returns

The Aytu Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Aytu Biopharma Inc investment value today

Current value as on today

₹2,23,629

Returns

₹1,23,629

(+123.63%)

Returns from Aytu Biopharma Inc Stock

₹1,13,710 (+113.71%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Aytu Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Aytu Biopharma Inc. Average target price of $9.67

Aytu Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Aytu Biopharma Inc.

What analysts predicted

72.6%UPSIDE

Target Price

$9.67

Current Price

$2.65

Analyzed by

7 Analysts

Target

$9.67

Aytu Biopharma Inc target price $9.67, a slight upside of 72.6% compared to current price of $2.65. According to 7 analysts rating.

Aytu Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for Aytu Biopharma Inc Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-3% versus previous 30 day period

Aytu Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
17
18
14
17
16
16
18
15
13
15
Gross Profit
13
14
10
11
11
10
12
10
9
9
Operating Income
0
3
-1
-3
0
-1
2
-7
-1
-1
EBITDA
-4
4
1
-5
3
2
6
-17
3
-9
Interest Expense
1
1
1
4
0
1
0
0
0
0
Depreciation
2
2
1
1
1
1
1
1
0
0
Income Before Tax
-7
1
-1
-3
1
0
3
-19
1
-10
Income Tax Expense
-2
0
0
0
0
0
0
0
-
-
Net Income
-8
0
-2
-4
1
0
3
-19
1
-10
Net Profit Margin
-45.57%
-1.17%
-20.58%
-25.68%
8.89%
4.86%
21.65%
-130.94%
14.15%
-69.79%

Aytu Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2016
Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
2
3
3
7
27
65
96
107
65
66
Gross Profit
1
1
1
5
19
29
50
66
49
45
Operating Income
-21
-20
-19
-16
-21
-58
-109
-17
-1
-7
EBITDA
-21
-18
-15
-14
-12
-29
-27
-3
1
-4
Interest Expense
5
2
0
-
-
37
147
4
4
3
Depreciation
-
4
2
2
6
9
10
4
8
5
Income Before Tax
-28
-22
-10
-27
-13
-58
-108
-17
-10
-13
Income Tax Expense
8
1
-2
20
-9
0
0
0
2
0
Net Income
-28
-22
-10
-47
-13
-58
-108
-17
-15
-13
Net Profit Margin
-1099.73%
-698.67%
-278.36%
-644.33%
-49.29%
-88.81%
-112.53%
-15.88%
-24.31%
-20.43%

Aytu Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
0
-2
-4
1
0
3
-19
1
-10
Operating Cash Flow
0
0
0
-1
2
-6
2
0
3
Investing Cash Flow
0
0
0
0
0
0
-3
-
0
Financing Cash Flow
0
0
1
0
-2
4
12
2
-6
Change in Cash
0
0
0
0
0
-2
12
1
-2

Aytu Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-22
-10
-27
-13
-58
-108
-17
-15
-13
Operating Cash Flow
-13
-15
-13
-28
-25
-28
-5
-1
-1
Investing Cash Flow
-3
0
-1
-5
-2
-3
0
0
-2
Financing Cash Flow
10
22
19
71
30
1
8
-1
15
Change in Cash
-7
6
4
37
1
-30
3
-2
10

Global Institutional Holdings in Aytu Biopharma Inc

Funds
Holdings
Nantahala Capital Management, LLC
10.13%
Diadema Partners LP
2.85%
Geode Capital Management, LLC
0.66%
Renaissance Technologies Corp
0.83%
XTX Topco Ltd
0.24%
See all

Insights on Aytu Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, AYTU has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 13.88M → 15.16M (in $), with an average increase of 8.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, AYTU stock has moved up by 15.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 142.7% return, outperforming this stock by 115.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.96M → -10.58M (in $), with an average decrease of 638.6% per quarter

About Aytu Biopharma Inc

aytu bioscience is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. aytu is initially concentrating on prostate cancer, male premature ejaculation and male infertility and plans to expand into other urological indications for which there are significant medical needs. the company currently markets prostascint®, an fda-approved radioimaging agent indicated to detect prostate specific membrane antigen (psma) in the assessment and staging of prostate cancer. the company’s most advanced therapeutic is zertane™, an oral therapeutic entering phase 3 clinical studies in the united states as an as needed treatment for premature ejaculation (pe). aytu is also conducting clinical trials with the company’s mioxsys™ system as a novel, point-of-care diagnostic system with the potential to become a standard of care in the diagnosis and management of male infertility.
OrganisationAytu Biopharma Inc
HeadquartersDenver Corporate Center III, Denver, CO, United States, 80237
IndustryConsumer Services
CEOMr. Joshua R. Disbrow
E-voting on sharesClick here to vote

Key Management of Aytu Biopharma Inc

Name

Title

Mr. Jarrett T. Disbrow Ph.D.

Chief Business Officer

Mr. Greg Pyszczymuka

Chief Commercial Officer

Ms. Margaret Cabano

Vice President of Operations

Dr. Gerwin Westfield Ph.D.

Senior Vice President of Scientific Affairs

Mr. Joshua R. Disbrow

CEO & Director

Mr. Ryan J. Selhorn CPA

CFO, Corporate Secretary & Treasurer

FAQs

What is Aytu Biopharma Inc share price today?

Aytu Biopharma Inc share price today is $2.65 as on at the close of the market. Aytu Biopharma Inc share today touched a day high of $2.65 and a low of $2.6.

What is the 52 week high and 52 week low for Aytu Biopharma Inc share?

Aytu Biopharma Inc share touched a 52 week high of $3.07 on and a 52 week low of $0.95 on . Aytu Biopharma Inc stock price today i.e. is closed at $2.65,which is 13.54% down from its 52 week high and 178.95% up from its 52 week low.

What is Aytu Biopharma Inc's market capitalisation today?

Aytu Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Aytu Biopharma Inc Stock (AYTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aytu Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aytu Biopharma Inc Shares that will get you 0.5660 shares as per Aytu Biopharma Inc share price of $2.65 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Aytu Biopharma Inc Stock (AYTU) from India?

Indian investors can start investing in Aytu Biopharma Inc (AYTU) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Aytu Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Aytu Biopharma Inc share’s latest price of $2.65 as on March 24, 2026 at 1:29 am IST, you will get 3.7736 shares of Aytu Biopharma Inc. Learn more about fractional shares .

What are the returns that Aytu Biopharma Inc has given to Indian investors in the last 5 years?

Aytu Biopharma Inc stock has given -98.48% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?